CompanyTrack
G

GLYCOSCOREDX LIMITED

Active Newcastle Upon Tyne

Manufacture of other chemical products n.e.c.

3 employees Website
Life sciences and medical technology Manufacture of other chemical products n.e.c.Agents specialized in the sale of other particular products +2
G

GLYCOSCOREDX LIMITED

Manufacture of other chemical products n.e.c.

Founded 24 Jul 2020 Active Newcastle Upon Tyne, United Kingdom 3 employees glycoscoredx.co.uk
Life sciences and medical technology Manufacture of other chemical products n.e.c.Agents specialized in the sale of other particular productsResearch and experimental development on biotechnologyOther human health activities
Accounts Submitted 17 Dec 2024
Confirmation Statement Submitted 23 Jul 2025
Net assets £145.92K
Total assets £169.32K £32.76K 2024 year on year
Total Liabilities £23.39K £178.68K 2024 year on year
Charges None No charges registered

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Registered Address

Sandgate House 102 Quayside Newcastle Upon Tyne Tyne And Wear NE1 3DX United Kingdom

Office ()

Newcastle Upon Tyne, Newcastle upon Tyne, United Kingdom, Europe

Credit Report

Discover GLYCOSCOREDX LIMITED's Credit Score, limit, and payment likelihood.

Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2021–2024)

Cash in Bank

£155.56k

Decreased by £37.31k (-19%)

Net Assets

£145.92k

Total Liabilities

£23.39k

Decreased by £178.68k (-88%)

Turnover

N/A

Employees

3

Decreased by 1 (-25%)

Debt Ratio

14%

Decreased by 86 (-86%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

£142k awarded
Show:

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

5 Allotments 1,398 Shares £632k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
21 Apr 2021420£590k£1k
21 Apr 202111£15k£1k
21 Apr 202118£25k£1k
20 Apr 2021855£855£855
15 Feb 202194£94£94

Officers

Officers

3 active 2 resigned
Status
Allan BrownDirectorBritishEngland643 Oct 2023Active
Jennifer MunkleyDirectorBritishUnited Kingdom4224 Jul 2020Active
Matthew Leslie PearceDirectorBritishEngland5513 Mar 2023Active

Shareholders

Shareholders (13)

Prostate Cancer Research
13.9%
1,94626 Jul 2023
Prostate Cancer Uk
9.3%
1,30026 Jul 2023
Oxbridge Capital Limited
0.1%
1126 Jul 2023

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased

Innovation Gp Limited

United Kingdom

Active
Notified 2 Jun 2023
Nature of Control
  • Ownership Of Shares 25 To 50 Percent
  • Voting Rights 25 To 50 Percent

Jennifer Munkley

Ceased 2 Jun 2023

Ceased

Group Structure

Group Structure

INNOVATION GP LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
NORTHSTAR VENTURES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
NORTHSTAR VENTURES HOLDINGS LIMITED united kingdom shares 50 to 75 percent, voting rights 50 to 75 percent
THE NORTHSTAR FOUNDATION united kingdom
GLYCOSCOREDX LIMITED Current Company

Charges

Charges

No charges registered

Documents

Company Filings

DateCategoryDescriptionDocument
23 Jul 2025Confirmation StatementConfirmation statement made on 2025-07-23 with no updatesView(3 pages)
17 Dec 2024AccountsAnnual accounts made up to 2024-07-31View(7 pages)
29 Jul 2024Confirmation StatementConfirmation statement made on 2024-07-23 with no updatesView(3 pages)
20 Mar 2024AccountsAnnual accounts made up to 2023-07-31View(8 pages)
6 Nov 2023OfficersAppointment of Mr Allan Brown as director on 2023-10-03View(2 pages)
23 Jul 2025 Confirmation Statement

Confirmation statement made on 2025-07-23 with no updates

17 Dec 2024 Accounts

Annual accounts made up to 2024-07-31

29 Jul 2024 Confirmation Statement

Confirmation statement made on 2024-07-23 with no updates

20 Mar 2024 Accounts

Annual accounts made up to 2023-07-31

6 Nov 2023 Officers

Appointment of Mr Allan Brown as director on 2023-10-03

Recent Activity

Latest Activity

Confirmation statement made on 2025-07-23 with no updates

6 months ago on 23 Jul 2025

Annual accounts made up to 2024-07-31

1 years ago on 17 Dec 2024

Confirmation statement made on 2024-07-23 with no updates

1 years ago on 29 Jul 2024

Annual accounts made up to 2023-07-31

1 years ago on 20 Mar 2024

Appointment of Mr Allan Brown as director on 2023-10-03

2 years ago on 6 Nov 2023